Skip to content

Update README.md #16

New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Merged
shiviancodes merged 1 commit into from
Jun 2, 2026
Merged

Update README.md #16

Changes from all commits
Commits
Show all changes
1 commit
Select commit
File filter

Filter by extension

Filter by extension
Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
2 changes: 1 addition & 1 deletion README.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -70,7 +70,7 @@ The same day, a real NVDA earnings guidance 8-K produced conviction=0.38 with a

---

## Research methodology
## Research methodology

Eleven factors were tested using HLZ multiple-testing correction at M=400 (Bonferroni threshold |t| >= 3.78). Every null result is documented in `docs/progress/` with full IC tables, regime splits, and bootstrap confidence intervals. An earlier backtest produced CAGR +14.3% and Sharpe 0.554, which was explicitly rejected after discovering that full-sample factor weights were applied at every rebalance -- approximately five years of look-ahead at the start of the window. The corrected result is CAGR +8.72%, Sharpe 0.488. The Phase 6 numbers do not appear anywhere in the current codebase as valid results. Three factors (momentum_12_1, size_proxy, gnn_drift) were flagged as declining by the trailing IC decay detector and removed from the aggregator before the corrected backtest was run.

Expand Down
Loading